Welcome to our dedicated page for UBS ETRACS Alerian MLP ETN Series B SEC filings (Ticker: AMUB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The ETRACS Alerian MLP Index ETN Series B due July 18, 2042 (AMUB) is issued by UBS AG, a foreign private issuer that reports to the US Securities and Exchange Commission. UBS AG indicates that it files a registration statement on Form F-3, including a prospectus and supplements, for offerings of securities related to ETRACS ETNs such as AMUB. These documents set out the terms of the ETN and include a "Risk Factors" section that UBS urges investors to review before investing.
UBS AG also submits annual reports on Form 20-F and periodic reports on Form 6-K. In its Form 6-K filings, UBS provides information on capitalization, total debt issued, equity and other capital and liquidity metrics, as well as updates on regulatory developments and other corporate matters. UBS AG notes that its consolidated financial statements are prepared in accordance with IFRS Accounting Standards, and that certain 6-K reports are incorporated by reference into its Form F-3 registration statement.
For AMUB, the relevant SEC filings include the base prospectus, prospectus supplements and any pricing supplements that describe the specific terms of the ETRACS Alerian MLP Index ETN Series B. UBS’s public materials state that these offering documents are available through the SEC’s EDGAR system. They also clarify that the securities related to the offerings are not deposit liabilities and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency of the United States, Switzerland or any other jurisdiction.
On this page, users can access AMUB-related SEC filings and associated issuer reports. The platform provides real-time updates from EDGAR and AI-powered summaries that explain the key points of lengthy documents, such as registration statements, prospectus supplements and UBS AG’s periodic reports. This allows investors to quickly identify disclosures that affect AMUB, including risk factor updates, capital and funding information, and other details relevant to UBS AG’s role as issuer of this senior unsecured ETN.
UBS AG filed an amended preliminary 424B3 for Trigger Callable Contingent Yield Notes linked to the iShares MSCI Brazil ETF (EWZ), maturing on or about October 15, 2027. The notes pay a 12.30% per annum contingent coupon on quarterly observation dates if EWZ closes at or above a coupon barrier set at 70.00% of the initial level. UBS may call the notes in whole on any observation date beginning after six months; if called, holders receive principal plus any due coupon.
If not called and the final level is at or above the downside threshold (70% of initial), holders receive the $1,000 principal. If below the threshold, holders receive a share delivery amount equal to $1,000 divided by the initial level, which could be worth significantly less than principal. The notes are unsecured obligations of UBS AG, not listed on an exchange, and subject to UBS credit risk.
Per-note economics include a $1,000 issue price, an underwriting discount of $18.50, and proceeds to UBS of $981.50. The estimated initial value is expected between
UBS AG is offering Trigger Autocallable Contingent Yield Notes linked to the Solactive U.S. Large Cap Volatility Navigator 40 Index, expected to mature on November 4, 2030. The Notes pay a 13.00% per annum contingent coupon only if the Index closes at or above the coupon barrier on each monthly observation date.
The Notes are callable after 12 months if the Index is at or above 100% of the initial level. Key levels are set at Call Threshold: 100% of the initial level, Coupon Barrier: 50%, and Downside Threshold: 50%. If not called and the final level is below the downside threshold, repayment is reduced one-for-one with the Index decline, and investors could lose all principal. Issue price is $1,000 per Note, with a $10 underwriting discount and $990 to UBS. The estimated initial value is expected between $933.80 and $963.80, reflecting internal pricing and funding assumptions. All payments depend on UBS’s credit.
UBS AG is offering Trigger Callable Contingent Yield Notes linked to the least performing of the Dow Jones Industrial Average, the Nasdaq‑100 Technology Sector Index, and the Russell 2000, maturing on or about October 19, 2028. The notes pay a 10.00% per annum contingent coupon only if each index closes at or above its coupon barrier on the applicable monthly observation date.
UBS may call the notes, in whole, on any observation date beginning after 3 months. If called, investors receive the $1,000 principal per note plus any due contingent coupon; no further payments are made. If not called and at least one index finishes below its downside threshold at final valuation, the maturity payment is reduced by the negative return of the least performing index, and investors could lose all principal. Payments depend on the creditworthiness of UBS.
Key terms include coupon barriers set at 70.00% of initial levels and downside thresholds at 60.00%. The estimated initial value is expected between
UBS AG is offering $15,041,000 of Capped Market‑Linked Notes tied to the least performing of the Dow Jones Industrial Average and the S&P 500 Index, due April 15, 2027.
At maturity, if the least performing index shows a positive return, the payout equals principal plus that return capped at a maximum gain of 11.20% (maximum payment $1,112 per $1,000 note). If the least performing return is zero or negative, repayment is principal only. The Notes pay no interest and are subject to UBS credit risk.
Key terms include an estimated initial value of $997.10 per note, an issue price of $1,000, and an underwriting discount of $1.50 per note (proceeds to UBS $998.50 per note). Trade date is October 10, 2025; final valuation April 12, 2027. The Notes will not be listed on any exchange.